TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of Participants Reporting Pain Freedom at 2 Hours Post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Reporting Pain Relief at 2 Hours Post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Experiencing an Adverse Event (AE) Within 48 Hours Post-dose
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of patients requiring invasive ventilatory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants having no symptomatic intracranial hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: No nausea rate
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of patients below specified antibiotic levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance and presence of microbial lineages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of clinical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pain over time as measured by 11-point numerical pain rating score (NPRS-11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain over time as measured by Pain Disability Index (PDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in 6-Minute Walk Test (6-MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Welch Emotional Connection Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in heart rhythm synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Social-Emotional Questionnaire (ASQ-SE) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Quantitative Muscle Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Benchmark rate of OA treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain/discomfort levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to close wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ADP 5 microM-induced maximal aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Investigator Global Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days out of the hospital, not on mechanical assistance
Endpoint domain: Mortality/survival
Primary endpoint: Mortality of acute decompensated heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Change in the Number of HIV Infected Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: increase of cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of contrast product used during the routine care procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disease severity and control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patterns of airway inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: microbial exposures and patterns of airway and gut microbial colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of total score of 17-item Hamilton Depression Rating Scale (HDRS-17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pressure areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incident CV event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity and Specificity of probe based endomicroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall response rate (probability of complete response [CR] or partial response [PR])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squatting to Standing Time postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Performance Physical Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Very Good Partial Response (VGPR) or Better Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete Response (CR) or Better Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in circulating microparticle counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of wound infection after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Visual analogue scale scores (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in adolescent's substance use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in plasma lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Cortisol During Trier Social Stress Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Metabolic Activity of Persistent Bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: carotid-to-femoral pulse wave velocity (cfPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Complete of 2 Cycles of APVD
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Event Free Survival at 1 Year
Endpoint domain: Mortality/survival
Primary endpoint: Metastatic Progression-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Count of Patients With Pathologic Complete Response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Count of Patients With Residual Cancer Burden (RCB) Scores of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical clearance of oral candidiasis by day 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Fungal clearance of oral candidiasis by saliva culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of individuals with initially positive usPCR tests followed by consecutive positive tests
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of individuals with initially negative usPCR tests that subsequently had at least one positive test
Endpoint domain: Adverse events/effects
Primary endpoint: Dosage of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway tissue temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractionated exhaled nitric oxide (FeNO) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Delayed recall deterioration rate (HVLT-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hernia Recurrence Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Baseline heart rate variability at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline heart rate at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from blood pressure at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from stress level at 30 min (salivary cortisol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from affect at 30 min (BRUMS/POMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Absolute Value of Gallbladder Ejection Fraction (Emax GEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Effect Curve for Gallbladder Ejection Fraction (AUEC GEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Absolute Change From Baseline in Value of Gallbladder Volume (Emax VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Physical Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virus load (VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Local Control Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPR Skills Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPR Skills Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean systolic blood pressure in 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean diastolic blood pressure in 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure dipping at night
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with Characteristics of inflammatory SPA/AS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who used etoricoxib
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients who used other COX-2 inhibitors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients who used nsNSAIDs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of clinical outcomes of special interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depression severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of individuals developing fever
Endpoint domain: Adverse events/effects
Primary endpoint: acute RTOG toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Chalder fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Rate of acute stroke recognized by the EMD during the emergency call
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rate at Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of a completely filled out questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Duration of Sensory Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 36 Item Short Form Survey (SF36) RAND
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Length of mechanical ventilation treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage difference in radioactivity between experimental and control thenar muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in sugar recovery in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in acne scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reinforcing effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with parasite clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serum Levels of High-sensitive C-reactive Protein (Hs-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Goniometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NPRS
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Number of alive and ICU-free days to day 28
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of children receiving Minimum Acceptable Diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PE use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnostic accuracy of biopsy needle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atherosclerotic burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Footwear comfort rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety and tolerability of compound 451238
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Sustained Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With an Ordinal Outcome on Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Victorian Institute of Sport Assessment (VISA-P) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline modified Blazina Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline thickness of patellar tendon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline Visual analogue score (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Proportion of venous ACT samples matching arterial ACT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Mean Hepatitis B Virus (HBV) DNA Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Accuracy of information collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in metabolic risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complications related to stent dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax: Maximum Observed Serum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-∞); Area Under the Serum Concentration-time Curve From Time Zero to Infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of an influenza vaccine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recanalization without symptomatic intracranial hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Device-related Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Procedure-related Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Disease Activity Score for 28 Different Joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to pain ≤ 1 on NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TCR Repertoire Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Cytokines Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cell-specific Gene Expression Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in lipid metabolism parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in resting energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in facultative thermogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in upper GI pain/discomfort intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Platelet function assay closure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percentage Change in Endothelium-dependent Flow-mediated Vasodilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Secretion of VLDL TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fractional Clearance Rate of VLDL TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall cost-effectiveness and acceptability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: glucose control in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Emergency Department visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of adverse reactions following vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: mortality at 30 days after admission to intensive care
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in Investigator's Static Global Assessment Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HCG Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change From Baseline in Psoriasis Area and Severity Index (PASI) Score at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Percent Body Surface Area (BSA) at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Dermatology Life Quality Index (DLQI) Score at Month 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prostate Biopsy Knowledge Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decision Self-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression-free Survival at 24 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free Survival at 12 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Product-related life-threatening adverse events, permanently disabling complications and deaths
Endpoint domain: Adverse events/effects
Primary endpoint: MRC Dyspnea Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Subdural hematoma volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Stable warfarin dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microperimetry recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recording of automated visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recording of eye movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Hemoglobin A1c (A1C) Levels at Week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With Hypoglycemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: CVC related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of tBRCAm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median time of pulmonary tuberculosis diagnosis confirmed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intellectual Competence Measured by IQ Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Unified Parkinson's Disease Rating Scale (UPDRS) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood oxygen saturation less than 90% of the total monitoring time percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lowest Oxygen Saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: atherosclerosis plaque thickness in common carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ovarian failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: 68Gallium-citrate and 18F-FDG uptake (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes